Clinical Research Inst of MI
Saint Clair Shores, Michigan 48081
1 studies enrolling now · 3 studies all time
What they study most
Diffuse Cutaneous Systemic Sclerosis, Polymyalgia Rheumatica
Studies at this site
- A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis — Recruiting now
- Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) — Running, not enrolling
- Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Polymyalgia Rheumatica (PMR) — Completed